Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,899,000 | 2,501,000 | -265,000 | 3,916,000 | 1,548,000 |
| Depreciation Amortization | 5,387,000 | 5,480,000 | 6,530,000 | 3,149,000 | 3,762,000 |
| Accounts receivable | -1,425,000 | -1,349,000 | -961,000 | -739,000 | -898,000 |
| Accounts payable and accrued liabilities | 2,394,000 | 1,165,000 | 1,405,000 | 1,721,000 | 868,000 |
| Other Working Capital | 300,000 | 3,757,000 | 2,021,000 | 361,000 | -346,000 |
| Other Operating Activity | -3,210,000 | -1,746,000 | -2,767,000 | -3,609,000 | -1,965,000 |
| Operating Cash Flow | $10,345,000 | $9,808,000 | $5,963,000 | $4,799,000 | $2,969,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 97,000 | -114,000 | 96,000 | 745,000 | 194,000 |
| PPE Investments | -1,229,000 | -809,000 | -1,078,000 | -855,000 | -942,000 |
| Net Acquisitions | -189,000 | -48,000 | -9,263,000 | -822,000 | -709,000 |
| Purchase Of Investment | -216,000 | -71,000 | -184,000 | -119,000 | -13,000 |
| Sale Of Investment | 32,000 | 42,000 | 785,000 | 1,381,000 | 18,000 |
| Purchase Sale Intangibles | -2,126,000 | -1,033,000 | -522,000 | -694,000 | 595,000 |
| Other Investing Activity | -2,559,000 | -1,960,000 | -1,414,000 | -615,000 | 795,000 |
| Investing Cash Flow | $-4,064,000 | $-2,960,000 | $-11,058,000 | $-285,000 | $-657,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 161,000 | 74,000 | -276,000 | 288,000 | -516,000 |
| Debt Issued | 3,816,000 | N/A | 12,929,000 | 2,968,000 | 500,000 |
| Debt Repayment | -4,942,000 | -1,271,000 | -4,759,000 | -1,609,000 | -1,500,000 |
| Common Stock Issued | 33,000 | 29,000 | 29,000 | 30,000 | 3,525,000 |
| Dividend Paid | -4,481,000 | -4,364,000 | -3,856,000 | -3,572,000 | -3,592,000 |
| Other Financing Activity | -1,154,000 | -1,291,000 | -418,000 | -308,000 | -182,000 |
| Financing Cash Flow | $-6,567,000 | $-6,823,000 | $3,649,000 | $-2,203,000 | $-1,765,000 |
| Exchange Rate Effect | -60,000 | -80,000 | -62,000 | 12,000 | 5,000 |
| Beginning Cash Position | 5,983,000 | 6,038,000 | 7,546,000 | 5,223,000 | 4,671,000 |
| End Cash Position | 5,637,000 | 5,983,000 | 6,038,000 | 7,546,000 | 5,223,000 |
| Net Cash Flow | $-346,000 | $-55,000 | $-1,508,000 | $2,323,000 | $552,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,345,000 | 9,808,000 | 5,963,000 | 4,799,000 | 2,969,000 |
| Capital Expenditure | -1,361,000 | -1,091,000 | -1,091,000 | -961,000 | -979,000 |
| Free Cash Flow | 8,984,000 | 8,717,000 | 4,872,000 | 3,838,000 | 1,990,000 |